The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 1683-1690

  George, Jacob ^a   Tharion, George ^a   Richard, J ^a   Macaden, Ashish S ^a   Thomas, Raji ^a   Bhattacharji, Suranjan ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Capsaicin; Intravesical; Neurogenic detrusor overactivity; Oxybutynin; Propantheline; Spinal cord injury

Indexed keywords

CAPSAICIN; NIFEDIPINE; OXYBUTYNIN; PROPANTHELINE BROMIDE;

ADULT; ARTICLE; AUTONOMIC DYSREFLEXIA; BLADDER NEUROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FREQUENCY ANALYSIS; HUMAN; INDIA; INTERMITTENT CATHETERIZATION; KRUSKAL WALLIS TEST; MALE; MUSCLE CONTRACTION; NEUROPATHY; PHYSICAL MEDICINE; SIDE EFFECT; SPINAL CORD INJURY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THIRST; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URODYNAMICS; XEROSTOMIA;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ADULT; CAPSAICIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MANDELIC ACIDS; MIDDLE AGED; PROPANTHELINE; SPINAL CORD INJURIES; TIME FACTORS; URINARY BLADDER, NEUROGENIC;

EID: 35848937138     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.271     Document Type: Article

References (24)

1. Reitz, A. and Schurch, B. (2004) Intravesical therapy options for neurogenic detrusor overactivity. Spinal Cord 42(5), 267-272.
2. Cruz, F. (2002) Vanilloid receptor and detrusor instability. Urology 59(5 Suppl 1), 51-60.
3. Fowler, C.J. (2002) Bladder afferents and their role in the overactive bladder. Urology 59(5 Suppl 1), 37-42.
4. Fowler, C.J. (2000) Intravesical treatment of overactive bladder. Urology 55(5A Suppl), 60-64.
5. Maggi, C.A., Barbanti, G., Santicioli, P., Beneforti, P., Misuri, D., Meli, A., et al. (1989) Cystometric evidence that capsaicin sensitive nerves modulate the afferent branch of micturition reflex in humans. J. Urol. 142, 150-154.
6. Prasad, K.V.R. and Baidyanathan, S. (1993) Intravesical oxybutynin chloride and clean intermittent catheterization in patients with neurogenic vesical dysfunction and decreased bladder capacity. Br. J. Urol. 72, 719-722.
7. Lehtoranta, K., Tainio, H., Lukkari-Lax, E., Hakonen, T., and Tammela, T.L. (2002) Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity. Scand. J. Urol. Nephrol. 36(1), 18-24.
8. Chancellor, M.B. and deGroat, W.C. (1999) Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat overactive bladder. J. Urol. 162, 3.
9. Fowler, C.J., Jewkes, D., McDonald, W.I., Lynn, B., and de Groat, W.C. (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339, 1239.
10. Wiart, L., Joseph, P.A., Petit, H., Dosque, J.P., de Seze, M., Brochet, B., et al. (1998) The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Spinal Cord 36(2), 95-99.
11. de Seze, M., Wiart, L., Joseph, P.A., Dosque, J.P., Mazaux, J.M., and Barat, M. (1998) Capsaicin and neurogenic detrusor hyperreflexia: a double blind placebo controlled study in 20 patients with spinal cord lesions. Neurourol. Urodyn. 17(5), 513-523.
12. Chandiramani, V.A., Peterson, T., Duthie, G.S., and Fowler, C.J. (1996) Urodynamic changes during intravesical instillations of capsaicin. Br. J. Urol. 77, 792-797.
13. Madersbacher, H. (1991) Control of detrusor hyperreflexia by intravesical instillation of oxybutynin hydrochloride. Paraplegia 29, 84-90.
14. Kasabian, N.G., Vlachiotis, J.D., Lais, A., Klumpp, B., Kelly, M.D., Siroky, M.B., et al. (1994) The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J. Urol. 151(4), 944-945.
15. Haferkamp, A., Staehler, G., Gerner, H.J., and Dorsam, J. (2000) Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients. Spinal Cord 38(4), 250-254.
16. Schwantes, U. and Topfmeier, P. (1999) Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia: chances for improvement of therapy. Int. J. Clin. Pharmacol. Ther. 37(5), 209-218.
17. Peterson, J.S. and Noronha-Blob, L. (1989) Effects of selective cholinergic antagonists and alpha, beta-methylene ATP on guinea-pig urinary bladder contractions in vivo following pelvic nerve stimulation. J. Auton. Pharmacol. 9(5), 303-313.
18. Peterson, J.S., Patton, A.J., and Noronha-Blob, L. (1990) Mini-pig urinary bladder function: comparisons of in vitro anticholinergic responses and in vivo cystometry with drugs indicated for urinary incontinence. J. Auton. Pharmacol. 10(2), 65-73.
19. Ukimura, O. (1993) Effects of intravesically administered anticholinergics, beta-adrenergic stimulant and alpha-adrenergic blocker on bladder function in unanaesthetized rats. Tohoku J. Exp. Med. 170(4), 251-260.
20. O'Flynn, K.J. and Thomas, D.G. (1993) Intravesical instillation of oxybutynin hydrochloride for detrusor hyperreflexia. Br. J. Urol. 72(5 Pt 1), 566-570.
21. Szollar, S.M. and Lee, S.M. (1996) Intravesical oxybutynin for spinal cord injury patients. Spinal Cord 34(5), 284-287.
22. Lazzeri, M., Spinelli, M., Beneforti, P., Zanollo, A., and Turini, D. (1999) Urodynamic assessment during intravesical infusion of capsaicin for the treatment of refractory detrusor hyperreflexia. Spinal Cord 37(6), 440-443.
23. Dasgupta, P., Chandiramani, V.A., Beckett, A., Scaravilli, F., and Fowler, C.J. (2000) The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia. BJU Int. 85(3), 238-245.
24. Fowler, C.J., Beck, R.O., Gerrard, S., Betts, C.D., and Fowler, C.G. (1994) Intravesical capsaicin for treatment of detrusor hyperreflexia. J. Neurol. Neurosurg. Psychiatry 57(2), 169-173.